Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Boyd Steven
Relationship:   10% Owner
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   18    
Direct Shares   47,075,098    

Indirect Shares

   40,287,245      
Direct Value   $124,110,593    

Indirect Value

   $39,455,039      
Total Shares   87,362,343      
Total Value   $163,565,632      


Avalo Therapeutics, Inc $14,783 Dynatronics Corp $233,800 Kiora Pharmaceuticals $625,814 Fresh Tracks Therapeutics Ord Shs $1,466,920 Alimera Sciences Inc $2,115,480 Cassava Sciences Inc $32,845,153 Bio-Path Holdings, Inc. $46,806 AYTU BIOSCIENCE, INC $3,852,625 Achieve Life Sciences Inc $4,294,820 AMAG Pharmaceuticals Inc $56,650,000 Onconova Therapeutics, Inc. $596,192 Vaxart Inc $109,128 Tenax Therapeutics Inc $524,997 Cyclo Therapeutics, Inc $19,902,669 ReShape Lifesciences Inc $831,407 Avalo Therapeutics, Inc $14,783 Dynatronics Corp $233,800 Kiora Pharmaceuticals $625,814 Fresh Tracks Therapeutics Ord Shs $1,466,920 Alimera Sciences Inc $2,115,480 Cassava Sciences Inc $32,845,153 Bio-Path Holdings, Inc. $46,806 AYTU BIOSCIENCE, INC $3,852,625 Achieve Life Sciences Inc $4,294,820 AMAG Pharmaceuticals Inc $56,650,000 Onconova Therapeutics, Inc. $596,192 Vaxart Inc $109,128 Tenax Therapeutics Inc $524,997 Cyclo Therapeutics, Inc $19,902,669 ReShape Lifesciences Inc $831,407
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    99   
    96    

     Stock price went up :
    54   
    46    
     Stock price went down :
    45   
    50    
   
     Gain/Loss Ratio :
   1.2   
   1.2   
     Percentage Gain/Loss :
   -16.7%
 8,928.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Avalo Therapeutics, Inc AVTX 10% Owner 2023-06-27 34,370 2023-06-27 731,458    Premium*  
            Dynatronics Corp DYNT 10% Owner 2017-03-21 500,000 2017-03-21 1,000,000    Premium*  
            Kiora Pharmaceuticals KPRX 10% Owner 2021-01-06 3,346,601 2021-08-02 785,000    Premium*  
            Fresh Tracks Therapeutics Ord Shs FRTX 10% Owner 2019-01-10 2,170,000 2019-01-10 2,170,000    Premium*  
            Alimera Sciences Inc ALIM 10% Owner 2018-02-06 6,936,000 2018-02-06 6,936,000    Premium*  
            Cassava Sciences Inc SAVA 10% Owner 2018-10-03 1,651,340 2018-10-03 0    Premium*  
            Del Friscos Restaurant Group, Llc DFRG 10% Owner 2019-09-25 0 2019-09-25 0    Premium*  
            Valeritas Holdings Inc VLRX 10% Owner 2019-12-20 0 2019-12-20 0    Premium*  
            Bio-Path Holdings, Inc. BPTH 10% Owner 2019-01-18 129,298 2019-01-18 129,298    Premium*  
            AYTU BIOSCIENCE, INC AYTU Director 2021-03-29 1,342,378 2021-03-29 1,342,378    Premium*  
            Achieve Life Sciences Inc ACHV 10% Owner 2019-06-11 843,776 2019-06-11 843,776    Premium*  
            AMAG Pharmaceuticals Inc AMAG 10% Owner 2020-03-16 4,120,000 2020-03-16 348,000    Premium*  
            Onconova Therapeutics, Inc. ONTX 10% Owner 2019-09-23 816,702 2019-09-23 816,702    Premium*  
            Vaxart Inc VXRT Director 2020-06-29 145,523 2020-06-29 145,523    Premium*  
            Tetraphase Pharmaceuticals Inc TTPH Director, 10% Owner 2020-07-28 0 2020-07-28 0    Premium*  
            Tenax Therapeutics Inc TENX Director, 10% Owner 2020-09-08 2,019,995 2020-09-08 2,019,995    Premium*  
            Cyclo Therapeutics, Inc CYTH 10% Owner 2020-09-30 15,795,769 2020-09-30 15,795,769    Premium*  
            ReShape Lifesciences Inc RSLS 10% Owner 2021-06-28 7,223,346 2021-06-28 7,223,346    Premium*  
* Premium Members only  

Records found :    790         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 26 of 32
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
AVTX Avalo Therapeutics, Inc Director   –       •       •   2019-08-30 4 B $3.23 $79,429 D/D 24,591 18,483,233 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-12-17 4 B $3.26 $48,701 D/D 14,938 18,082,970 3.92 -
KPRX Kiora Pharmaceuticals Director   –       •       •   2021-07-28 4 S $3.28 $1,232,617 I/I (375,443) 1,445,963 0 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2019-08-13 4 B $3.30 $96,320 I/I 29,188 343,158 2.25 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-12-18 4 B $3.31 $23,262 D/D 7,030 18,090,000 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-12-14 4 B $3.33 $93,445 D/D 28,032 18,068,032 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-04-16 4 B $3.36 $137,885 D/D 41,096 16,091,096 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-12-10 4 B $3.36 $46,397 D/D 13,815 18,040,000 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2019-08-14 4 B $3.37 $191,558 D/D 56,842 400,000 3.92 -
VXRT Vaxart Inc Director   –       •       •   2020-04-28 4 S $3.38 $4,367,197 D/D (1,292,070) 23,907,930 0 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-12-04 4 B $3.40 $7,488 D/D 2,200 18,003,600 3.84 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-12-07 4 B $3.40 $21,254 D/D 6,185 18,026,185 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-04-18 4 B $3.41 $278,391 D/D 81,544 16,200,000 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2019-01-04 4 B $3.42 $68,320 I/I 20,000 18,148,799 2.25 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2019-08-16 4 B $3.43 $33,909 D/D 9,886 18,439,171 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-12-06 4 B $3.44 $56,494 D/D 16,400 18,020,000 3.92 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2018-11-29 4 B $3.48 $61,946 D/D 17,803 17,977,803 2.45 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-11-30 4 B $3.50 $14,351 D/D 4,102 17,981,905 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-12-03 4 B $3.50 $68,314 D/D 19,495 18,001,400 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2019-08-19 4 B $3.50 $8,280 D/D 2,298 18,441,469 3.84 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-04-17 4 B $3.51 $96,097 D/D 27,360 16,118,456 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-05-15 4 B $3.51 $325,535 D/D 92,700 16,312,700 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-11-19 4 B $3.51 $84,746 D/D 23,800 17,836,000 3.92 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2018-11-27 4 B $3.51 $93,430 D/D 26,654 17,926,654 2.45 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2018-11-28 4 B $3.52 $117,488 D/D 33,346 17,960,000 2.45 -
  790  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26  27   28   29   30   31   32      
  Page 26 of 32  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us